Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV magnesium supplementation in critically ill adults in ICU
ACTRN12619000925145Phase 2Completed
- Sponsor
- Austin Hospital
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of magnesium sulfate in hypomagnesaemia, sponsored by Austin Hospital. Primary endpoint: Concentration of serum magnesium. Started Jul 2019; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
hypomagnesaemia
Beyond the preview
Go deeper on ACTRN12619000925145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000925145.